Biodesix Inc SEC filings BDSX

Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Biodesix Inc SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 5, 2026 Nov 2, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Aug 13, 2026 Aug 12, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 18, 2026 —
424B3 Prospectus Jun 1, 2026 —
EFFECT Filing May 29, 2026 —
CORRESP Letter to the SEC May 27, 2026 —
UPLOAD Letter from the SEC May 26, 2026 —
S-3 Shelf registration May 21, 2026 —
8-K Current report
Shareholder vote results
May 20, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 9, 2026 —
DEF 14A Proxy statement Apr 9, 2026 May 19, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
144 Notice of proposed sale Feb 23, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
S-8 Employee stock plan registration Feb 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 27, 2026 —
4 Insider transaction Jan 27, 2026 Jan 23, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 26, 2026 —
4 Insider transaction Jan 26, 2026 Jan 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 23, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 13, 2026 —
8-K/A Amended current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Nov 13, 2025 Nov 10, 2025
4 Insider transaction Nov 13, 2025 Nov 10, 2025
4 Insider transaction Nov 13, 2025 Nov 10, 2025
4 Insider transaction Nov 13, 2025 Nov 10, 2025
4 Insider transaction Nov 13, 2025 Nov 10, 2025
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 1, 2025 Sep 26, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 23, 2025 —
4 Insider transaction Sep 23, 2025 Sep 19, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 15, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 11, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 3, 2025 —
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 14, 2025 Aug 12, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jul 1, 2025
S-8 Employee stock plan registration May 30, 2025 —
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
8-K Current report
Shareholder vote results
May 21, 2025 May 20, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 20, 2025 —
4 Insider transaction May 20, 2025 May 16, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 28, 2025 May 20, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 May 20, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 15, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
8-K Current report
Listing notice
Mar 28, 2025 Mar 24, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
4 Insider transaction Feb 26, 2025 Feb 20, 2025
4 Insider transaction Feb 26, 2025 Feb 20, 2025
4 Insider transaction Feb 26, 2025 Feb 20, 2025
4 Insider transaction Feb 26, 2025 Feb 20, 2025
4 Insider transaction Feb 26, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
S-8 Employee stock plan registration Feb 7, 2025 —
8-K Current report
Results of operations
Jan 10, 2025 Jan 10, 2025
4 Insider transaction Nov 22, 2024 Nov 21, 2024
4 Insider transaction Nov 22, 2024 Nov 21, 2024
4 Insider transaction Nov 21, 2024 Nov 20, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
EFFECT Filing Nov 12, 2024 —
EFFECT Filing Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
424B5 Prospectus supplement Nov 12, 2024 —
CORRESP Letter to the SEC Nov 7, 2024 —
CORRESP Letter to the SEC Nov 7, 2024 —
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
4 Insider transaction Nov 6, 2024 Nov 5, 2024
UPLOAD Letter from the SEC Nov 6, 2024 —
UPLOAD Letter from the SEC Nov 6, 2024 —
S-3 Shelf registration Nov 1, 2024 —
S-3 Shelf registration Nov 1, 2024 —
10-Q Quarterly report Nov 1, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 1, 2024 Nov 1, 2024
8-K Current report
Regulation FD disclosure
Aug 15, 2024 Aug 14, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
424B5 Prospectus supplement Aug 7, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
4 Insider transaction Jul 18, 2024 Jul 16, 2024
SC 13G Ownership over 5% (passive) Jun 24, 2024 —
424B3 Prospectus Jun 5, 2024 —
EFFECT Filing Jun 4, 2024 —
CORRESP Letter to the SEC May 31, 2024 —
S-1/A Amended registration statement May 24, 2024 —
CORRESP Letter to the SEC May 24, 2024 —
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 23, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 23, 2024
4 Insider transaction May 23, 2024 May 23, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 23, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
SC 13D/A Amended ownership over 5% (active) May 23, 2024 —
SC 13D/A Amended ownership over 5% (active) May 23, 2024 —
8-K Current report
Shareholder vote results
May 23, 2024 May 21, 2024
UPLOAD Letter from the SEC May 17, 2024 —
SC 13G Ownership over 5% (passive) May 13, 2024 —
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024
144 Notice of proposed sale May 9, 2024 —
144 Notice of proposed sale May 9, 2024 —
144 Notice of proposed sale May 9, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BDSX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Louisville, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1439725

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.